TL;DR
This study investigates PAXgene-fixed paraffin-embedded (PFPE) tissue as a potential alternative to standard formalin-fixed paraffin-embedded (FFPE) tissue for diagnosing Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC). The findings suggest PFPE offers comparable or even superior histological quality, particularly for nuclear details, while also preserving biomolecules for downstream analysis, making it a promising tool for integrated diagnostics.
What Problem Does This Paper Address?
The diagnosis and grading of dysplasia in Barrett's esophagus (BE), a precancerous condition of the esophagus, relies heavily on histomorphological assessment of formalin-fixed, paraffin-embedded (FFPE) tissue. However, this process is plagued by significant interobserver variability among pathologists, leading to an unsatisfactory prediction of cancer risk. This variability hinders effective risk stratification and treatment decisions. Furthermore, while FFPE tissues are valuable for historical archives, the cross-linking nature of formalin can degrade biomolecules (DNA, RNA, proteins), limiting their utility for advanced molecular and genetic analyses that could offer more objective risk prediction. The paper addresses the need for a pre-analytic fixation method that preserves both tissue morphology for accurate diagnosis and biomolecules for molecular analysis, aiming to improve the prediction of cancer risk in BE.
Methods
The study employed an international ring trial involving nine experienced gastrointestinal pathologists. They evaluated 116 digital slides of BE and esophageal adenocarcinoma (EAC) samples, with a balanced mix of diagnostic categories (non-dysplastic BE (NDBE), low-grade dysplasia (LGD), high-grade dysplasia (HGD), and EAC). Crucially, the slides were prepared using two fixation methods: standard formalin-fixed paraffin-embedded (FFPE) and a novel PAXgene-fixed paraffin-embedded (PFPE) method. The PFPE method uses a non-cross-linking fixative designed to preserve both morphology and biomolecules.
Pathologists assessed various criteria using virtual microscopy, including:
- Quality criteria: Nuclear details (chromatin, nucleoli, mitosis), basal lamina, goblet cells, and artifacts.
- BE/EAC-specific features: Atypical mitosis, abnormal shapes, border irregularities, pseudostratification, crowding, invasiveness, and surface maturation.
- Overall quality and final diagnosis: Based on hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) stained slides, using the Vienna classification.
The study compared the quality scores and diagnostic reproducibility between the two fixation methods. Interobserver reproducibility was assessed using Fleiss' kappa statistics.
Datasets
The study utilized a dataset of 116 Barrett's esophagus biopsy cases. These cases were divided into two groups based on fixation method:
- FFPE group: 59 cases (15 NDBE, 15 LGD, 15 HGD, 14 EAC)
- PFPE group: 57 cases (14 NDBE, 15 LGD, 14 HGD, 14 EAC)
These cases were retrieved from the BarrettNET registry at the Technical University of Munich. The dataset was designed to be representative of the diagnostic spectrum of BE and EAC. No new benchmark datasets were introduced; rather, existing cases were processed using two different fixation methods for direct comparison.
Key Insights and Ideas
- Superior Nuclear Detail Preservation: PFPE fixation demonstrably preserves nuclear details like chromatin and nucleoli better than FFPE. This enhanced clarity could be crucial for subtle diagnostic features.
- Comparable Histomorphological Quality: Despite the better nuclear preservation, overall histomorphological quality, including features like basal lamina, goblet cells, and artifact presence, was found to be comparable between PFPE and FFPE. This suggests PFPE doesn't compromise the standard diagnostic assessment.
- Potential for Integrated Diagnostics: The core idea is that PFPE offers a dual benefit: it's suitable for histomorphological diagnosis (like FFPE) and it preserves biomolecules for molecular analysis. This opens the door for a more comprehensive diagnostic approach, combining visual assessment with molecular insights for better risk prediction.
- Interobserver Variability Persists: While PFPE shows promise, it doesn't magically solve the inherent interobserver variability in grading dysplasia, particularly for LGD and HGD. This highlights that while fixation is important, the subjective nature of interpreting subtle morphological changes remains a challenge.
Key Results
- Nuclear Quality: PFPE samples were scored significantly better for chromatin and nucleoli quality (p=0.02 and p=0.01, respectively) compared to FFPE. Over 65% of PFPE samples were rated "excellent" or "good" for these features, versus ~50% for FFPE.
- Other Quality Parameters: Quality of basal lamina, mucin/goblet cells, and overall quality did not differ significantly between PFPE and FFPE (p=0.65, 0.49, and 0.48, respectively). Artifacts (retraction and edge) also showed no significant differences.
- Diagnostic Reproducibility: Interobserver agreement was highest for NDBE (κ=0.72) and EAC (κ=0.75), and poor for LGD (κ=0.13-0.3) in both fixation methods. This pattern of variability is consistent with previous studies and was not significantly improved by PFPE.
- Diagnosis Frequencies: Most pathologists showed no significant difference in their diagnostic frequencies between FFPE and PFPE samples.
- Pathologist Confidence: Pathologists reported feeling equally confident in their diagnoses regardless of the fixation method, with "sure" ratings in approximately 75% of cases.
Limitations and Future Work
- Interobserver Variability: The study acknowledges that while PFPE offers good histological quality, it does not resolve the fundamental issue of interobserver variability in dysplasia grading, especially for LGD and HGD. This remains a significant challenge for BE diagnostics.
- Sample Size: While 116 cases is a reasonable number for a ring trial, larger datasets could further strengthen the findings.
- Future Work: The authors suggest that PFPE's ability to preserve biomolecules makes it an ideal candidate for integrating molecular and histomorphological analyses. This could lead to the development of more objective biomarkers for risk prediction and personalized treatment strategies. The potential for AI-driven diagnostics, which could benefit from the enhanced nuclear detail and contrast offered by PFPE, is also highlighted. Further research could explore the specific molecular data obtainable from PFPE and its direct correlation with clinical outcomes.
Summary updated